Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vacc-4x re-boosting follow-up study in HIV-1 patients on ART
2012-002281-12Phase 2Completed
- Sponsor
- Immunor
- Start
- Aug 2012
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Vacc-4x and sargramostim in Human immunodeficiency virus infection type 1, sponsored by Immunor. Primary endpoint: Viral load set point. Started Aug 2012; status: completed.
02
Drugs
Vacc-4xsargramostim
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2012-002281-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002281-12.